PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $37,000 | +12.1% | 13,082 | +3.0% | 0.00% | – |
| Q3 2018 | $33,000 | -19.5% | 12,704 | -27.3% | 0.00% | – |
| Q2 2018 | $41,000 | -50.0% | 17,477 | -37.6% | 0.00% | -100.0% |
| Q1 2018 | $82,000 | -5.7% | 28,023 | -12.2% | 0.00% | 0.0% |
| Q4 2017 | $87,000 | -37.4% | 31,911 | -22.2% | 0.00% | -50.0% |
| Q3 2017 | $139,000 | +36.3% | 41,028 | -0.2% | 0.00% | +100.0% |
| Q2 2017 | $102,000 | -1.9% | 41,122 | -10.5% | 0.00% | -50.0% |
| Q1 2017 | $104,000 | +7.2% | 45,966 | +0.2% | 0.00% | 0.0% |
| Q4 2016 | $97,000 | -25.4% | 45,862 | +18.6% | 0.00% | 0.0% |
| Q3 2016 | $130,000 | +17.1% | 38,668 | +9.5% | 0.00% | 0.0% |
| Q2 2016 | $111,000 | -55.1% | 35,311 | -52.3% | 0.00% | -66.7% |
| Q1 2016 | $247,000 | -5.0% | 74,099 | +1.0% | 0.01% | 0.0% |
| Q4 2015 | $260,000 | -34.2% | 73,368 | -6.5% | 0.01% | -45.5% |
| Q3 2015 | $395,000 | -14.9% | 78,441 | +8.7% | 0.01% | -15.4% |
| Q2 2015 | $464,000 | +176.2% | 72,185 | +202.0% | 0.01% | +160.0% |
| Q1 2015 | $168,000 | – | 23,903 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |